In a variety of cancers, IL-6/JAK/STAT3 is overactivated, which promotes tumor cell proliferation, survival, invasiveness and metastasis and inhibits the antitumor immune response, which is related to the poor prognosis of tumors (19). The gene discussed is IL6; the disease is neoplasm.